Cresco assisted the founders and shareholders of BISC Global Holding with the structuring, negotiation and closing of the sale of the BISC group, a bioinformatics and data analytics consultancy expert with offices in several European countries and the US, to Excelra, one of the world’s leading life science data and digital solutions providers.
Founded in 2017 by an experienced team of bioinformaticians, statisticians and entrepreneurs BISC Global has grown to be a top 10 bioinformatics consulting and services firm supporting leading pharmaceutical and biotech companies all over the world. From their headquarters in Ghent, and offices in Switzerland, the Netherlands, Boston and San Francisco (USA), their goal is to help clients overcome their challenges in data analysis, pipeline automation, visualization and computational environments.
The Excelra group in turn provides data, insight, and R&D technology services to the world’s top pharmaceutical and biotech companies. From offices in Boston, Utrecht, London, and Hyderabad, Excelra’s interdisciplinary teams of biocurators, bioinformaticians, data scientists, and engineers deliver harmonized data, optimized analysis pipelines, and advanced applications to accelerate drug discovery and development.
The acquisition of BISC Global by Excelra creates a game-changing bioinformatics powerhouse, committed to driving innovation at the intersection of science and technology.
The Cresco deal team consisted of Olivier Van Raemdonck, Glenn L’hoëst and Veerle Brusseleers.
More information on this transaction can be found here.
Don’t hesitate to contact Olivier Van Raemdonck or Glenn L’hoëst in case of any questions.